MeSH D001987 - bronchiectasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Rising Pharmaceuticals | Acetylcysteine | Acetylcysteine |  | 2015-03-24 |  |  |
| Zydus Therapeutics | Acetylcysteine | Acetylcysteine |  | 2018-07-20 |  |  |
| Hospira | Acetylcysteine | Acetylcysteine |  | 1989-05-01 |  |  |
| Arbor Pharmaceuticals | Acetylcysteine | Cetylev | 2032-05-08 | 2016-01-29 |  |  |
| Bristol Myers Squibb | Acetylcysteine | Mucomyst |  | 1982-01-01 |  |  |
| Alvogen | Acetylcysteine | Acetylcysteine |  | 2012-06-21 |  |  |
| Cumberland Pharmaceuticals | Acetylcysteine | Acetadote | 2025-08-24 | 2004-01-23 | $0.407 M | Q3/24-Q2/25 |
| Roxane Laboratories | Acetylcysteine | Acetylcysteine |  | 1992-04-30 |  |  |
| Eugia Pharma Specialties | Acetylcysteine | Acetylcysteine |  | 2016-02-29 |  |  |
| Fresenius Kabi | Acetylcysteine | Acetylcysteine |  | 2012-11-07 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
43%3/7
Phase 2
57%8/14
Phase 3
33%5/15
Approved: 1Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use